0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Celiac Disease Market Research Report 2023
Published Date: April 2023
|
Report Code: QYRE-Auto-28G2866
Home | Market Reports | Health| Nutrition| Special & Restricted Diets
Global Celiac Disease Market Insights and Forecast to 2028
BUY CHAPTERS

Global Celiac Disease Market Research Report 2023

Code: QYRE-Auto-28G2866
Report
April 2023
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Celiac Disease Market

The global Celiac Disease market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Celiac Disease is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Celiac Disease is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Celiac Disease in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Celiac Disease include Roche, Merck, Johnson & Johnson, BiolineRx, Pfizer, Innovate Biopharmaceuticals, ImmusanT, Novartis and Bristol-Myers Squibb, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Celiac Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Celiac Disease.
The Celiac Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Celiac Disease market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Celiac Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • Roche
  • Merck
  • Johnson & Johnson
  • BiolineRx
  • Pfizer
  • Innovate Biopharmaceuticals
  • ImmusanT
  • Novartis
  • Bristol-Myers Squibb
  • Immunomedics

Segment by Type

  • Distension
  • Diarrhea
  • Anorexia
  • Others

Segment by Application

  • Hospital
  • Clinic

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Celiac Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global Celiac Disease Market Report

Report MetricDetails
Report NameGlobal Celiac Disease Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Celiac Disease Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Distension
1.2.3 Diarrhea
1.2.4 Anorexia
1.2.5 Others
1.3 Market by Application
1.3.1 Global Celiac Disease Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Celiac Disease Market Perspective (2018-2029)
2.2 Celiac Disease Growth Trends by Region
2.2.1 Global Celiac Disease Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Celiac Disease Historic Market Size by Region (2018-2023)
2.2.3 Celiac Disease Forecasted Market Size by Region (2024-2029)
2.3 Celiac Disease Market Dynamics
2.3.1 Celiac Disease Industry Trends
2.3.2 Celiac Disease Market Drivers
2.3.3 Celiac Disease Market Challenges
2.3.4 Celiac Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Celiac Disease Players by Revenue
3.1.1 Global Top Celiac Disease Players by Revenue (2018-2023)
3.1.2 Global Celiac Disease Revenue Market Share by Players (2018-2023)
3.2 Global Celiac Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Celiac Disease Revenue
3.4 Global Celiac Disease Market Concentration Ratio
3.4.1 Global Celiac Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Celiac Disease Revenue in 2022
3.5 Celiac Disease Key Players Head office and Area Served
3.6 Key Players Celiac Disease Product Solution and Service
3.7 Date of Enter into Celiac Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Celiac Disease Breakdown Data by Type
4.1 Global Celiac Disease Historic Market Size by Type (2018-2023)
4.2 Global Celiac Disease Forecasted Market Size by Type (2024-2029)
5 Celiac Disease Breakdown Data by Application
5.1 Global Celiac Disease Historic Market Size by Application (2018-2023)
5.2 Global Celiac Disease Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Celiac Disease Market Size (2018-2029)
6.2 North America Celiac Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Celiac Disease Market Size by Country (2018-2023)
6.4 North America Celiac Disease Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Celiac Disease Market Size (2018-2029)
7.2 Europe Celiac Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Celiac Disease Market Size by Country (2018-2023)
7.4 Europe Celiac Disease Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Celiac Disease Market Size (2018-2029)
8.2 Asia-Pacific Celiac Disease Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Celiac Disease Market Size by Region (2018-2023)
8.4 Asia-Pacific Celiac Disease Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Celiac Disease Market Size (2018-2029)
9.2 Latin America Celiac Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Celiac Disease Market Size by Country (2018-2023)
9.4 Latin America Celiac Disease Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Celiac Disease Market Size (2018-2029)
10.2 Middle East & Africa Celiac Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Celiac Disease Market Size by Country (2018-2023)
10.4 Middle East & Africa Celiac Disease Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Celiac Disease Introduction
11.1.4 Roche Revenue in Celiac Disease Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Celiac Disease Introduction
11.2.4 Merck Revenue in Celiac Disease Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Celiac Disease Introduction
11.3.4 Johnson & Johnson Revenue in Celiac Disease Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 BiolineRx
11.4.1 BiolineRx Company Detail
11.4.2 BiolineRx Business Overview
11.4.3 BiolineRx Celiac Disease Introduction
11.4.4 BiolineRx Revenue in Celiac Disease Business (2018-2023)
11.4.5 BiolineRx Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Celiac Disease Introduction
11.5.4 Pfizer Revenue in Celiac Disease Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Innovate Biopharmaceuticals
11.6.1 Innovate Biopharmaceuticals Company Detail
11.6.2 Innovate Biopharmaceuticals Business Overview
11.6.3 Innovate Biopharmaceuticals Celiac Disease Introduction
11.6.4 Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2018-2023)
11.6.5 Innovate Biopharmaceuticals Recent Development
11.7 ImmusanT
11.7.1 ImmusanT Company Detail
11.7.2 ImmusanT Business Overview
11.7.3 ImmusanT Celiac Disease Introduction
11.7.4 ImmusanT Revenue in Celiac Disease Business (2018-2023)
11.7.5 ImmusanT Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Celiac Disease Introduction
11.8.4 Novartis Revenue in Celiac Disease Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Celiac Disease Introduction
11.9.4 Bristol-Myers Squibb Revenue in Celiac Disease Business (2018-2023)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Immunomedics
11.10.1 Immunomedics Company Detail
11.10.2 Immunomedics Business Overview
11.10.3 Immunomedics Celiac Disease Introduction
11.10.4 Immunomedics Revenue in Celiac Disease Business (2018-2023)
11.10.5 Immunomedics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Celiac Disease Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Distension
    Table 3. Key Players of Diarrhea
    Table 4. Key Players of Anorexia
    Table 5. Key Players of Others
    Table 6. Global Celiac Disease Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Celiac Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Celiac Disease Market Size by Region (2018-2023) & (US$ Million)
    Table 9. Global Celiac Disease Market Share by Region (2018-2023)
    Table 10. Global Celiac Disease Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 11. Global Celiac Disease Market Share by Region (2024-2029)
    Table 12. Celiac Disease Market Trends
    Table 13. Celiac Disease Market Drivers
    Table 14. Celiac Disease Market Challenges
    Table 15. Celiac Disease Market Restraints
    Table 16. Global Celiac Disease Revenue by Players (2018-2023) & (US$ Million)
    Table 17. Global Celiac Disease Market Share by Players (2018-2023)
    Table 18. Global Top Celiac Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease as of 2022)
    Table 19. Ranking of Global Top Celiac Disease Companies by Revenue (US$ Million) in 2022
    Table 20. Global 5 Largest Players Market Share by Celiac Disease Revenue (CR5 and HHI) & (2018-2023)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Celiac Disease Product Solution and Service
    Table 23. Date of Enter into Celiac Disease Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Celiac Disease Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Global Celiac Disease Revenue Market Share by Type (2018-2023)
    Table 27. Global Celiac Disease Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 28. Global Celiac Disease Revenue Market Share by Type (2024-2029)
    Table 29. Global Celiac Disease Market Size by Application (2018-2023) & (US$ Million)
    Table 30. Global Celiac Disease Revenue Market Share by Application (2018-2023)
    Table 31. Global Celiac Disease Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 32. Global Celiac Disease Revenue Market Share by Application (2024-2029)
    Table 33. North America Celiac Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 34. North America Celiac Disease Market Size by Country (2018-2023) & (US$ Million)
    Table 35. North America Celiac Disease Market Size by Country (2024-2029) & (US$ Million)
    Table 36. Europe Celiac Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Europe Celiac Disease Market Size by Country (2018-2023) & (US$ Million)
    Table 38. Europe Celiac Disease Market Size by Country (2024-2029) & (US$ Million)
    Table 39. Asia-Pacific Celiac Disease Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 40. Asia-Pacific Celiac Disease Market Size by Region (2018-2023) & (US$ Million)
    Table 41. Asia-Pacific Celiac Disease Market Size by Region (2024-2029) & (US$ Million)
    Table 42. Latin America Celiac Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. Latin America Celiac Disease Market Size by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Celiac Disease Market Size by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Celiac Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 46. Middle East & Africa Celiac Disease Market Size by Country (2018-2023) & (US$ Million)
    Table 47. Middle East & Africa Celiac Disease Market Size by Country (2024-2029) & (US$ Million)
    Table 48. Roche Company Detail
    Table 49. Roche Business Overview
    Table 50. Roche Celiac Disease Product
    Table 51. Roche Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
    Table 52. Roche Recent Development
    Table 53. Merck Company Detail
    Table 54. Merck Business Overview
    Table 55. Merck Celiac Disease Product
    Table 56. Merck Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
    Table 57. Merck Recent Development
    Table 58. Johnson & Johnson Company Detail
    Table 59. Johnson & Johnson Business Overview
    Table 60. Johnson & Johnson Celiac Disease Product
    Table 61. Johnson & Johnson Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
    Table 62. Johnson & Johnson Recent Development
    Table 63. BiolineRx Company Detail
    Table 64. BiolineRx Business Overview
    Table 65. BiolineRx Celiac Disease Product
    Table 66. BiolineRx Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
    Table 67. BiolineRx Recent Development
    Table 68. Pfizer Company Detail
    Table 69. Pfizer Business Overview
    Table 70. Pfizer Celiac Disease Product
    Table 71. Pfizer Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
    Table 72. Pfizer Recent Development
    Table 73. Innovate Biopharmaceuticals Company Detail
    Table 74. Innovate Biopharmaceuticals Business Overview
    Table 75. Innovate Biopharmaceuticals Celiac Disease Product
    Table 76. Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
    Table 77. Innovate Biopharmaceuticals Recent Development
    Table 78. ImmusanT Company Detail
    Table 79. ImmusanT Business Overview
    Table 80. ImmusanT Celiac Disease Product
    Table 81. ImmusanT Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
    Table 82. ImmusanT Recent Development
    Table 83. Novartis Company Detail
    Table 84. Novartis Business Overview
    Table 85. Novartis Celiac Disease Product
    Table 86. Novartis Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
    Table 87. Novartis Recent Development
    Table 88. Bristol-Myers Squibb Company Detail
    Table 89. Bristol-Myers Squibb Business Overview
    Table 90. Bristol-Myers Squibb Celiac Disease Product
    Table 91. Bristol-Myers Squibb Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
    Table 92. Bristol-Myers Squibb Recent Development
    Table 93. Immunomedics Company Detail
    Table 94. Immunomedics Business Overview
    Table 95. Immunomedics Celiac Disease Product
    Table 96. Immunomedics Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
    Table 97. Immunomedics Recent Development
    Table 98. Research Programs/Design for This Report
    Table 99. Key Data Information from Secondary Sources
    Table 100. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Celiac Disease Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Celiac Disease Market Share by Type: 2022 VS 2029
    Figure 3. Distension Features
    Figure 4. Diarrhea Features
    Figure 5. Anorexia Features
    Figure 6. Others Features
    Figure 7. Global Celiac Disease Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Celiac Disease Market Share by Application: 2022 VS 2029
    Figure 9. Hospital Case Studies
    Figure 10. Clinic Case Studies
    Figure 11. Celiac Disease Report Years Considered
    Figure 12. Global Celiac Disease Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 13. Global Celiac Disease Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Celiac Disease Market Share by Region: 2022 VS 2029
    Figure 15. Global Celiac Disease Market Share by Players in 2022
    Figure 16. Global Top Celiac Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease as of 2022)
    Figure 17. The Top 10 and 5 Players Market Share by Celiac Disease Revenue in 2022
    Figure 18. North America Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. North America Celiac Disease Market Share by Country (2018-2029)
    Figure 20. United States Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Canada Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Celiac Disease Market Share by Country (2018-2029)
    Figure 24. Germany Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. France Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. U.K. Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Italy Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Russia Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Nordic Countries Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Celiac Disease Market Share by Region (2018-2029)
    Figure 32. China Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Japan Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. South Korea Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Southeast Asia Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. India Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Australia Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Celiac Disease Market Share by Country (2018-2029)
    Figure 40. Mexico Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Brazil Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Celiac Disease Market Share by Country (2018-2029)
    Figure 44. Turkey Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Saudi Arabia Celiac Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Roche Revenue Growth Rate in Celiac Disease Business (2018-2023)
    Figure 47. Merck Revenue Growth Rate in Celiac Disease Business (2018-2023)
    Figure 48. Johnson & Johnson Revenue Growth Rate in Celiac Disease Business (2018-2023)
    Figure 49. BiolineRx Revenue Growth Rate in Celiac Disease Business (2018-2023)
    Figure 50. Pfizer Revenue Growth Rate in Celiac Disease Business (2018-2023)
    Figure 51. Innovate Biopharmaceuticals Revenue Growth Rate in Celiac Disease Business (2018-2023)
    Figure 52. ImmusanT Revenue Growth Rate in Celiac Disease Business (2018-2023)
    Figure 53. Novartis Revenue Growth Rate in Celiac Disease Business (2018-2023)
    Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Celiac Disease Business (2018-2023)
    Figure 55. Immunomedics Revenue Growth Rate in Celiac Disease Business (2018-2023)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS